Medpace Holdings, Inc. (MEDP) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Medpace financial statements at a glance

Medpace reported revenue of $2.53 billion for fiscal year 2025 (ended December 31, 2025), up 19.9% from fiscal year 2024. Net income was $451.12 million, a net margin of 17.8%.

At the end of fiscal year 2025 it had total assets of $1.98 billion, total liabilities of $1.52 billion and shareholders' equity of $459.07 million, with cash and short-term investments of $497.05 million and total debt of $113.64 million.

Its operations brought in $713.22 million of cash; capital spending was $31.36 million, leaving free cash flow of $681.87 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

MEDP logo

Medpace Holdings, Inc.

MEDPUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
2.53B
Prev Year: 2.11B
YoY: +19.9%
Operating Revenue
2.53B
Prev Year: 2.11B
YoY: +19.9%
Total Other Finance Cost
-12.78M
Prev Year: -25.00M
YoY: +48.9%
Depreciation Amortization Depletion
28.12M
Prev Year: 29.25M
YoY: -3.8%
Depreciation and amortization
28.12M
Prev Year: 29.25M
YoY: -3.8%
Amortization
946.0K
Prev Year: 1.44M
YoY: -34.3%
Amortization of Intangibles
946.0K
Prev Year: 1.44M
YoY: -34.3%
Depreciation
27.18M
Prev Year: 27.81M
YoY: -2.3%
Cost of Revenue
1.77B
Prev Year: 1.45B
YoY: +22.0%
Gross Profit
760.62M
Prev Year: 656.30M
YoY: +15.9%
Operating Expense
225.68M
Prev Year: 209.44M
YoY: +7.8%
Selling General and Administrative
197.56M
Prev Year: 180.18M
YoY: +9.6%
Operating Income
534.93M
Prev Year: 446.87M
YoY: +19.7%
Net Non Operating Interest Income Expense
12.78M
Prev Year: 25.00M
YoY: -48.9%
Other Income Expense
-5.34M
Prev Year: 4.06M
YoY: -231.5%
Gain on Sale of Securities
-7.73M
Prev Year: 0
Other Non-operating Income (expense)
2.39M
Prev Year: 4.55M
YoY: -47.4%
Special Income Charges
-
Pre-tax Income
542.38M
Prev Year: 475.92M
YoY: +14.0%
Provision for Income Taxes
91.25M
Prev Year: 71.54M
YoY: +27.6%
Net Income Common Stockholders
451.12M
Prev Year: 404.34M
YoY: +11.6%
Net Income
451.12M
Prev Year: 404.39M
YoY: +11.6%
Net Income Including Non-Controlling Interests
451.12M
Prev Year: 404.39M
YoY: +11.6%
Net Income from Continuing Operations
451.12M
Prev Year: 404.39M
YoY: +11.6%
Diluted NI Available to Com Stockholders
451.12M
Prev Year: 404.34M
YoY: +11.6%
Total Operating Income as Reported
534.93M
Prev Year: 446.87M
YoY: +19.7%
Basic EPS
-
Prev Year: 13.06
Total Expenses
2.00B
Prev Year: 1.66B
YoY: +20.2%
Diluted EPS
-
Prev Year: 12.63
Net Income from Continuing and Discontinued Operation
451.12M
Prev Year: 404.39M
YoY: +11.6%
Weighted Average Shares (basic)
-
Prev Year: 30.96M
Normalized Income
457.56M
Prev Year: 404.81M
YoY: +13.0%
Weighted Average Shares (diluted)
-
Prev Year: 32.01M
Net Interest Income
12.78M
Prev Year: 25.00M
YoY: -48.9%
EBIT
534.93M
Prev Year: 446.87M
YoY: +19.7%
EBITDA
563.06M
Prev Year: 476.12M
YoY: +18.3%
Reconciled Cost of Revenue
1.77B
Prev Year: 1.45B
YoY: +22.0%
Reconciled Depreciation
28.12M
Prev Year: 29.25M
YoY: -3.8%
Interest Expense
-
Net Income from Continuing Operation Net Minority Interest
451.12M
Prev Year: 404.39M
YoY: +11.6%
Total Unusual Items Excluding Goodwill
-7.73M
Prev Year: 0
Total Unusual Items
-7.73M
Prev Year: 0
Normalized EBITDA
570.79M
Prev Year: 476.62M
YoY: +19.8%
Tax Rate for Calcs
0.168
Prev Year: 0.15
YoY: +12.0%
Tax Effect of Unusual Items
-1.30M
Prev Year: 0
Values in USD

Medpace key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$2.5B$2.1B$1.9B$1.5B$1.1B
Gross profit$760.6M$656.3M$524.5M$432.4M$328.2M
Operating income$534.9M$446.9M$336.8M$278.7M$198.6M
Net income$451.1M$404.3M$282.6M$245.2M$181.4M
Diluted EPS–$12.63$8.88$7.28$4.81
Total assets$2.0B$2.1B$1.7B$1.4B$1.7B
Total liabilities$1.5B$1.3B$1.1B$966.1M$707.0M
Shareholders' equity$459.1M$825.5M$559.0M$386.4M$952.9M
Cash and short-term investments$497.0M$669.4M$245.5M$28.3M$461.3M
Total debt$113.6M$126.2M$142.1M$188.9M$131.0M
Operating cash flow$713.2M$608.8M$433.4M$388.1M$263.3M
Capital spending$31.4M$36.6M$36.7M$36.9M$28.3M
Free cash flow$681.9M$572.3M$396.7M$351.2M$235.1M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2014.

Questions and answers

What was Medpace's revenue in fiscal year 2025?

$2.53 billion, up 19.9% from $2.11 billion in fiscal year 2024.

How much profit does Medpace make?

Medpace reported net income of $451.12 million for fiscal year 2025 (17.8% of revenue); operating income was $534.94 million.

How much cash and debt does Medpace have?

At the end of fiscal year 2025: cash and short-term investments of $497.05 million and total debt of $113.64 million.

What is Medpace's free cash flow?

$681.87 million in fiscal year 2025 (operating cash flow of $713.22 million minus capital spending of $31.36 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube